News | August 24, 2025
Akums Drugs and Pharmaceuticals signs framework agreement with Govt. of Zambia
This project shall be implemented through incorporation of a new joint venture company in Zambia
This project shall be implemented through incorporation of a new joint venture company in Zambia
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
The projected business potential is around US$ 1 million in the first year
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
The agreement complements other PPAs for Sandoz production sites globally
Cupid reported total income of Rs. 64.75 crore in Q1 FY26 as compared to Rs. 44.03 crore in Q1 Fy25
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
Subscribe To Our Newsletter & Stay Updated
